Magic Mushrooms in The Garden State? A Look Into the Proposed Psilocybin Legal Landscape in New Jersey

New Jersey Law Journal (reprinted with permission)

9.22.2022

This article in the New Jersey Law Journal, co-authored by Lisa Gora and Wilentz associate Natalie Moszczynski, discusses the recent updates in state legislatures regarding Psilocybin, a naturally occurring psychedelic, and how its' legalization would impact decriminalization, de-prioritization, and scientific and medical research. 

*Cannabis Law Disclaimer: Per federal law, under the Controlled Substances Act, marijuana is categorized as a Schedule I controlled substance.  Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy, regardless of any state law that may authorize certain marijuana activity.  Compliance with state marijuana law does not equal compliance with federal law.  Legal advice provided by Wilentz, Goldman & Spitzer, P.A. is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Wilentz, Goldman & Spitzer, P.A. will not provide guidance or assistance in circumventing or violating Federal or state cannabis law or policy, and any advice provided by Wilentz, Goldman & Spitzer, P.A. should not be construed as such.